Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Prasugrel Hydrochloride (LY 640315 Hydrochloride) 是一种噻吩吡啶和前药,是一种可口服的P2Y12受体拮抗剂,抑制 ADP 诱导的血小板聚集,用于预防急性冠状动脉综合征患者的血栓形成、不稳定型心绞痛和心肌梗塞,以及接受经皮冠状动脉介入治疗的患者。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 125 | 现货 | ||
10 mg | ¥ 169 | 现货 | ||
25 mg | ¥ 259 | 现货 | ||
50 mg | ¥ 372 | 现货 | ||
100 mg | ¥ 538 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 239 | 现货 |
产品描述 | Prasugrel Hydrochloride (LY 640315 Hydrochloride) is a piperazine derivative and pletelet aggregation inhibitor that is used to prevent thrombosis in patients with acute coronary syndrome. |
靶点活性 | Platelet:1.8 μM. |
体内活性 | Prasugrel significantly inhibits arterio-venous (AV) shunt and electrically induced arterial thrombosis in single dose ranges of 0.3 to 3 mg/kg and of 0.3 and 1 mg/kg/day for multiple doses. These doses are similar to doses with inhibition of platelet activation via P2Y12 receptors, suggesting that the protective effects of prasugrel in these cerebral infarction and peripheral arterial occlusive disease models reflect P2Y12 inhibitions on platelets by prasugrel's active metabolite. Prasugrel also significantly prevents progression of peripheral vascular lesions[1]. |
别名 | LY 640315, PCR 4099 (hydrochloride), 盐酸普拉格雷, Effient Hydrochloride, LY 640315 Hydrochloride, Prasugrel HCl |
分子量 | 409.9 |
分子式 | C20H20FNO3S·HCl |
CAS No. | 389574-19-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 43 mg/mL (104.9 mM)
Ethanol: 9 mg/mL (21.95 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.4396 mL | 12.1981 mL | 24.3962 mL | 60.9905 mL |
5 mM | 0.4879 mL | 2.4396 mL | 4.8792 mL | 12.1981 mL | |
10 mM | 0.244 mL | 1.2198 mL | 2.4396 mL | 6.099 mL | |
20 mM | 0.122 mL | 0.6099 mL | 1.2198 mL | 3.0495 mL | |
DMSO | 50 mM | 0.0488 mL | 0.244 mL | 0.4879 mL | 1.2198 mL |
100 mM | 0.0244 mL | 0.122 mL | 0.244 mL | 0.6099 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Prasugrel Hydrochloride 389574-19-0 GPCR/G Protein Neuroscience P2Y Receptor LY640315 aggregation LY 640315 platelet Inhibitor PCR-4099 antiplatelet LY-640315 Hydrochloride ADP PCR 4099 active PCR4099 PCR 4099 (hydrochloride) metabolite 盐酸普拉格雷 LY640315 Hydrochloride inhibit Effient Hydrochloride LY-640315 Prasugrel LY 640315 Hydrochloride Prasugrel HCl inhibitor